Moreover, Solyom et al. reported a novel germline ABRAXAS mutation (p.Arg361Gln) in Northern Finnish breast cancer families which affects the nuclear localization of the protein and consequently reduces the formation of BRCA1 and Rap80 foci at DNA damage sites, leading to ionizing radiation hypersensitivity of cells and partially impairing the G2/M checkpoint [65]. The gene discussed is BRCA1; the disease is breast cancer.